Mesa Laboratories, Inc.
MLAB
$107.64
$1.601.51%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 60.14M | 63.72M | 65.13M | 60.74M | 59.54M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 60.14M | 63.72M | 65.13M | 60.74M | 59.54M |
| Cost of Revenue | 21.13M | 21.52M | 23.33M | 23.41M | 22.60M |
| Gross Profit | 39.01M | 42.21M | 41.80M | 37.33M | 36.94M |
| SG&A Expenses | 27.26M | 34.21M | 28.79M | 27.56M | 28.89M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 53.11M | 60.98M | 57.15M | 56.01M | 56.48M |
| Operating Income | 7.03M | 2.75M | 7.98M | 4.72M | 3.06M |
| Income Before Tax | 4.35M | -1.59M | 4.60M | 2.00M | 7.01M |
| Income Tax Expenses | 1.52M | 2.54M | 966.00K | -477.00K | 2.27M |
| Earnings from Continuing Operations | 2.83M | -4.14M | 3.63M | 2.48M | 4.74M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 2.83M | -4.14M | 3.63M | 2.48M | 4.74M |
| EBIT | 7.03M | 2.75M | 7.98M | 4.72M | 3.06M |
| EBITDA | 12.68M | 8.50M | 13.69M | 10.57M | 9.02M |
| EPS Basic | 0.50 | -0.75 | 0.66 | 0.45 | 0.87 |
| Normalized Basic EPS | 0.48 | -0.18 | 0.52 | 0.23 | 0.80 |
| EPS Diluted | 0.49 | -0.75 | 0.65 | 0.45 | 0.85 |
| Normalized Diluted EPS | 0.47 | -0.18 | 0.52 | 0.23 | 0.79 |
| Average Basic Shares Outstanding | 5.66M | 5.54M | 5.53M | 5.51M | 5.47M |
| Average Diluted Shares Outstanding | 5.76M | 5.54M | 5.57M | 5.54M | 5.55M |
| Dividend Per Share | 0.16 | 0.16 | 0.16 | 0.16 | 0.16 |
| Payout Ratio | 31.24% | -21.37% | 24.35% | 35.62% | 18.41% |